● Recruiting

A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)

Condition: Autosomal Recessive Polycystic Kidney (ARPKD) · Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

PhasePhase 3

Planned participants20

Who can joinAll sexes, 28 Days to 18 Years

Healthy volunteersNo

About this study

To evaluate the pharmacodynamics and safety of tolvaptan in pediatric subjects with ARPKD

This description comes directly from the study's public registry record.

Talk to the study team

Otsuka Call Center · 844-687-8522 · Otsuka-ProfessionalServices@otsuka-us.com

Always discuss trial participation with your own doctor first.

Locations (23)

Children's National Medical Center	Washington D.C., District of Columbia, United States	Recruiting
Emory University Hospital	Atlanta, Georgia, United States	Withdrawn
Northwestern University Feinberg School of Medicine - Ann & Robert H. Lurie Children's Hospital of Chicago - Neonatology	Chicago, Illinois, United States	Withdrawn
Riley Hospital for Children	Indianapolis, Indiana, United States	Withdrawn
Children's Hospital - New Orleans	New Orleans, Louisiana, United States	Withdrawn
Johns Hopkins Pediatric Specialty Clinic	Baltimore, Maryland, United States	Recruiting
C.S. Mott Children's Hospital	Ann Arbor, Michigan, United States	Recruiting
Mayo Clinic - Rochester	Rochester, Minnesota, United States	Recruiting
Cincinnati Children's Hospital Medical Center	Cincinnati, Ohio, United States	Recruiting
Cleveland Clinic	Cleveland, Ohio, United States	Recruiting
Children's Hospital of Pittsburgh of UPMC	Pittsburgh, Pennsylvania, United States	Withdrawn
Primary Children's Hospital	Salt Lake City, Utah, United States	Withdrawn

+ 11 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04782258